178 related articles for article (PubMed ID: 24319173)
1. Pharmacogenomics of acute lymphoid leukemia: new insights into treatment toxicity and efficacy.
Relling MV; Ramsey LB
Hematology Am Soc Hematol Educ Program; 2013; 2013():126-30. PubMed ID: 24319173
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics in acute lymphoblastic leukemia.
Cheok MH; Pottier N; Kager L; Evans WE
Semin Hematol; 2009 Jan; 46(1):39-51. PubMed ID: 19100367
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenomics of childhood acute lymphoblastic leukemia.
Brenner TL; Pui CH; Evan WE
Curr Opin Mol Ther; 2001 Dec; 3(6):567-78. PubMed ID: 11804271
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenomics of acute lymphoblastic leukemia.
Kager L; Evans WE
Curr Opin Hematol; 2006 Jul; 13(4):260-5. PubMed ID: 16755223
[TBL] [Abstract][Full Text] [Related]
5. Acute lymphoblastic leukaemia: a model for the pharmacogenomics of cancer therapy.
Cheok MH; Evans WE
Nat Rev Cancer; 2006 Feb; 6(2):117-29. PubMed ID: 16491071
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetics of acute lymphoblastic leukemia treatment response.
Cunningham L; Aplenc R
Expert Opin Pharmacother; 2007 Oct; 8(15):2519-31. PubMed ID: 17931087
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenomic effects on therapy for acute lymphoblastic leukemia in children.
Wall AM; Rubnitz JE
Pharmacogenomics J; 2003; 3(3):128-35. PubMed ID: 12815362
[No Abstract] [Full Text] [Related]
8. Genomic strategies to improve outcome and individualize therapy in cancer: the paradigm of childhood acute lymphoblastic leukemia.
Kager L
J BUON; 2009 Sep; 14 Suppl 1():S181-6. PubMed ID: 19785064
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenomics in acute lymphoblastic leukemia.
Lee SHR; Yang JJ
Best Pract Res Clin Haematol; 2017 Sep; 30(3):229-236. PubMed ID: 29050696
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenomics of acute leukemia.
Ansari M; Krajinovic M
Pharmacogenomics; 2007 Jul; 8(7):817-34. PubMed ID: 18240908
[TBL] [Abstract][Full Text] [Related]
11. Role of pharmacogenomics and pharmacodynamics in the treatment of acute lymphoblastic leukaemia.
Pui CH; Relling MV; Evans WE
Best Pract Res Clin Haematol; 2002 Dec; 15(4):741-56. PubMed ID: 12617874
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenomics in pediatric leukemia.
Paugh SW; Stocco G; Evans WE
Curr Opin Pediatr; 2010 Dec; 22(6):703-10. PubMed ID: 20861736
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacogenomics of acute lymphoblastic leukemia].
Ansari M; St-Onge G; Krajinovic M
Med Sci (Paris); 2007 Nov; 23(11):961-7. PubMed ID: 18021708
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetic Predictors of Treatment-Related Toxicity Among Children With Acute Lymphoblastic Leukemia.
Maxwell RR; Cole PD
Curr Hematol Malig Rep; 2017 Jun; 12(3):176-186. PubMed ID: 28317081
[TBL] [Abstract][Full Text] [Related]
15. Investigation of inherited noncoding genetic variation impacting the pharmacogenomics of childhood acute lymphoblastic leukemia treatment.
Bhattarai KR; Mobley RJ; Barnett KR; Ferguson DC; Hansen BS; Diedrich JD; Bergeron BP; Yoshimura S; Yang W; Crews KR; Manring CS; Jabbour E; Paietta E; Litzow MR; Kornblau SM; Stock W; Inaba H; Jeha S; Pui CH; Cheng C; Pruett-Miller SM; Relling MV; Yang JJ; Evans WE; Savic D
Nat Commun; 2024 May; 15(1):3681. PubMed ID: 38693155
[TBL] [Abstract][Full Text] [Related]
16. Genome study suggests new treatments for high-risk form of childhood leukemia.
McBride D
ONS Connect; 2012 Nov; 27(11):21. PubMed ID: 23316525
[No Abstract] [Full Text] [Related]
17. Pharmacogenetics influence treatment efficacy in childhood acute lymphoblastic leukemia.
Davidsen ML; Dalhoff K; Schmiegelow K
J Pediatr Hematol Oncol; 2008 Nov; 30(11):831-49. PubMed ID: 18989161
[TBL] [Abstract][Full Text] [Related]
18. Role of miRNAs in treatment response and toxicity of childhood acute lymphoblastic leukemia.
Umerez M; Garcia-Obregon S; Martin-Guerrero I; Astigarraga I; Gutierrez-Camino A; Garcia-Orad A
Pharmacogenomics; 2018 Mar; 19(4):361-373. PubMed ID: 29469670
[TBL] [Abstract][Full Text] [Related]
19. Clinical Application of Thiopurine Pharmacogenomics in Pediatrics.
Pavlovic S; Kotur N; Stankovic B; Gasic V; Lucafo M; Decorti G; Zukic B
Curr Drug Metab; 2020; 21(1):53-62. PubMed ID: 32124692
[TBL] [Abstract][Full Text] [Related]
20. The Promise of Pharmacogenomics in Reducing Toxicity During Acute Lymphoblastic Leukemia Maintenance Treatment.
Rudin S; Marable M; Huang RS
Genomics Proteomics Bioinformatics; 2017 Apr; 15(2):82-93. PubMed ID: 28391009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]